市场调查报告书
商品编码
1597155
亚太地区非侵入性减脂市场预测至 2031 年 - 区域分析 - 按技术(冷冻溶脂、雷射溶脂、超音波等)和最终用户(医院、皮肤科和美容诊所以及其他最终用户)Asia Pacific Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others) and End User (Hospitals, Dermatology & Cosmetic Clinics, and Other End Users) |
2023年亚太地区非侵入性减脂市值为4.1508亿美元,预计2031年将达到17.0985亿美元;预计2023年至2031年复合年增长率为19.4%。
产品核准与创新推动亚太无创减脂市场
下表重点介绍了市场上营运的公司推出的以非侵入性减脂为中心的产品。
日期
公司名称
产品名称
产品描述
1 月 21 日
艾伯维公司
酷塑精英
CoolSculpting Elite 是一项经过临床验证的技术,可靶向、冷冻和消除经过处理的脂肪细胞。该产品已获得 FDA 批准,可治疗身体九个区域的可见脂肪隆起,包括大腿、腹部和侧腹,以及胸罩脂肪、背部脂肪、臀部下方、上臂以及颏下和下颌下区域。
4 月 22 日
超大型油轮
VLCC Lipo-1060
VLCC Lipo-1060 治疗采用最新的特定波长雷射装置,可实现无痛的非侵入性塑身瘦身,并确保在保护皮肤的情况下仅消除脂肪细胞。治疗中使用的技术已被临床证明可以持续减少腹部和身体其他部位的脂肪轮廓,并且对所有皮肤类型都具有出色的安全性。
23年3月
truBody品牌
truBody 品牌是一款屡获殊荣的疗程组合,旨在提供客製化、方便、完整的减脂和肌肉塑形方法,疗程仅需 15 分钟。用于减脂的 truSculpt(以前称为 truSculpt iD)是一种快速有效的组合方法,使医生和患者能够提供减脂和塑形肌肉的最佳效果。
此外,Medicis 的 Liposonix 是一种新的治疗技术,使用高强度聚焦超音波设备来消除皮下脂肪。据报道,该公司获得 FDA 批准用于非侵入性腰围缩小。此类创新产品的批准和推出预计将在 2023 年至 2031 年期间促进非侵入性减脂市场的成长。
亚太地区无创减脂市场概况
亚太地区包括中国、日本、印度、澳洲、韩国等主要国家、亚太地区其他地区。亚太地区非手术减脂市场复合年增长率最高。在亚太地区,中国在非手术减脂市场上占有主要份额。对美容手术的需求不断增长是影响2023-2031年预测期内非手术减脂市场区域成长的关键因素之一。
亚太地区无创减脂市场收入及 2031 年预测(百万美元)
亚太地区无创减脂市场区隔
亚太地区无创减脂市场按技术、最终用户和国家分类。
根据技术,亚太无创减脂市场分为冷冻溶脂、雷射溶脂、超音波等。 2023 年,冷冻溶脂领域占据最大的市场份额。
就最终用户而言,亚太地区非侵入性减脂市场分为医院、皮肤科诊所和美容诊所等。 2023 年,皮肤科诊所和美容诊所细分市场占据最大的市场份额。
依国家/地区划分,亚太地区无创减脂市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年,中国在亚太无创减脂市场份额中占据主导地位。
Cynosure LLC、Alma Lasers Ltd、Cutera Inc、Fotona、Sciton Inc、Lumenis、Venus Concept Inc 和 Candela Corporation 是亚太地区非侵入性减脂市场的一些领先公司。
The Asia Pacific noninvasive fat reduction market was valued at US$ 415.08 million in 2023 and is projected to reach US$ 1,709.85 million by 2031; it is estimated to register a CAGR of 19.4% from 2023 to 2031.
Product Approvals and Innovations Boost Asia Pacific Noninvasive Fat Reduction Market
The table below highlights the noninvasive fat reduction-centric products launched by companies operating in the market.
Date
Company Name
Product Name
Product Description
Jan-21
AbbVie, Inc.
CoolSculpting Elite
CoolSculpting Elite is a clinically proven technology to target, freeze, and eliminate treated fat cells. The product is FDA-cleared to treat visible fat bulges in nine areas of the body, including the thigh, abdomen, and flank, as well as bra fat, back fat, underneath the buttocks, upper arm, and the submental and submandibular areas.
Apr-22
VLCC
VLCC Lipo-1060
VLCC Lipo-1060 treatment uses the latest laser appliances of specific wavelengths that enable noninvasive body contouring and slimming without pain and ensure that only fat cells are eliminated with skin protection. The technology used in the treatment has been clinically proven to consistently reduce the fat contour in the abdomen and other areas of the body, with an excellent safety profile in all skin types.
Mar-23
truBody Brand
truBody Brand is an award-winning treatment pair intended for a customized, convenient, and complete approach to fat reduction and muscle toning with only a 15-minute treatment duration. The truSculpt (formerly truSculpt iD) for fat reduction is a fast and effective combination approach, allowing practitioners and patients to provide optimal results for reducing fat and toning muscle.
Additionally, Medicis's Liposonix is a new treatment technique that uses a high-intensity focused ultrasound device to eliminate fat beneath the skin. The company reportedly received FDA approval for noninvasive waist circumference reduction. Such innovative product approvals and launches are expected to enhance the market growth of noninvasive fat reduction during 2023 - 2031.
Asia Pacific Noninvasive Fat Reduction Market Overview
Asia Pacific region covers major countries such as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Asia Pacific region accounts highest CAGR for the non-surgical fat reduction market. In the Asia Pacific region, China holds major share for the non-surgical fat reduction market. Rising demand for aesthetic procedures is one of the key factors that influences regional growth of non-surgical fat reduction market for the forecast period 2023-2031.
Asia Pacific Noninvasive Fat Reduction Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Noninvasive Fat Reduction Market Segmentation
The Asia Pacific noninvasive fat reduction market is categorized into technology, end user, and country.
Based on technology, the Asia Pacific noninvasive fat reduction market is categorized into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held the largest market share in 2023.
In terms of end user, the Asia Pacific noninvasive fat reduction market is segmented into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held the largest market share in 2023.
By country, the Asia Pacific noninvasive fat reduction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific noninvasive fat reduction market share in 2023.
Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton Inc, Lumenis, Venus Concept Inc, and Candela Corporation are some of the leading companies operating in the Asia Pacific noninvasive fat reduction market.